The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Mouse and human dendritic cell subtypes
Shortman, K., & Liu, Y.-J. (2002) · Nature Reviews Immunology · doi:10.1038/nri746 · Cited by 2,291
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citationHarding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. H., & Allison, J. P. (1992) · Nature · doi:10.1038/356607a0 · Cited by 1,559
Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,358
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationBonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Self-citationGabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Self-citationRegulation of T Cell Immunity by Dendritic Cells
Lanzavecchia, A., & Sallusto, F. (2001) · Cell · doi:10.1016/s0092-8674(01)00455-x · Cited by 997
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Self-citationExpression of relB is required for the development of thymic medulla and dendritic cells
Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconl, L. A., Olson, D., Tizard, R., Gate, R., & Lo, D. (1995) · Nature · doi:10.1038/373531a0 · Cited by 780
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Self-citationJAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610 · cited 1×
“Although JAK activation might contribute to the specificity of the receptors, the JAKs are not absolute determinants of the specificity of cytokine-mediated signalling, because different cytokines can activate the same JAKs (reviewed in Ref”
BackgroundKaliński, P., Hilkens, C. M., Snijders, A., Snijdewint, F. G., & Kapsenberg, M. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.28 · Cited by 602
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Terabe, M., Matsui, S., Park, J.-M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022227 · Cited by 539
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Self-citationRegulation of the NF-ηB/rel transcription factor and IηB inhibitor system
Liou, H.-C., & Baltimore, D. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90014-h · Cited by 535
Prospective isolation of human clonogenic common myeloid progenitors
Manz, M. G., Miyamoto, T., Akashi, K., & Weissman, I. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172384399 · Cited by 534
Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L. D., Carbone, D. P., & Gabrilovich, D. I. (1998) · PubMed · Cited by 530
Self-citationSerafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
Park, S.-J., Nakagawa, T., Kitamura, H., Atsumi, T., Kamon, H., Sawa, S.-I., Kamimura, D., Ueda, N., Iwakura, Y., Ishihara, K., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3844 · Cited by 519
IL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Enk, A. H., Angeloni, V. L., Udey, M. C., & Katz, S. I. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2390 · Cited by 501
Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., & Mantovani, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<359::aid-immu359>3.0.co;2-4 · Cited by 486
Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1224 · Cited by 481
Self-citationJanus kinases: components of multiple signaling pathways
Rane, S. G., & Reddy, E. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203925 · Cited by 466
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Self-citationGabrilovich, D. I., Ishida, T., Nadaf, S., Ohm, J. E., & Carbone, D. P. (1999) · PubMed · Cited by 459
Self-citationSteinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G. R., Tura, S., et al. (2002) · Blood · doi:10.1182/blood.v100.1.230 · Cited by 442
Decreased antigen presentation by dendritic cells in patients with breast cancer.
Gabrilovich, D. I., Corak, J., Ciernik, I. F., Kavanaugh, D., & Carbone, D. P. (1997) · PubMed · Cited by 429
Self-citationBronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405
Dendritic Cell Development and Survival Require Distinct NF-κB Subunits
Ouaaz, F., Arron, J., Zheng, Y., Choi, Y., & Beg, A. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00272-8 · Cited by 390
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
Enk, A. H., Jonuleit, H., Saloga, J., & Knop, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3 · Cited by 386
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
Danna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A., & Ostrand-Rosenberg, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2646 · Cited by 371
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., & Saito, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13119 · Cited by 338
Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Self-citationSieczkiewicz, G. J., Hussain, M., & Kohn, E. C. (2002) · Ovarian Cancer · doi:10.1007/978-1-4757-3587-1_17 · Cited by 295
Melani, C., Chiodoni, C., Forni, G., & Colombo, M. P. (2003) · Blood · doi:10.1182/blood-2003-01-0190 · Cited by 295
Ellis, L. M., & Fidler, I. J. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00389-9 · Cited by 293
Some interfaces of dendritic cell biology
STEINMAN, R. M. (2003) · APMIS · doi:10.1034/j.1600-0463.2003.11107802.x · Cited by 292
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
Kusmartsev, S., & Gabrilovich, D. I. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103010 · Cited by 292
Self-citationDendritic Cells in Antitumor Immune Responses
Gabrilovich, D. I., Ciernik, I. F., & Carbone, D. P. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0139 · Cited by 289
Self-citationStructure, organization, and function of glycosphingolipids in membrane
Hakomori, S. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00004 · Cited by 283
YU, Z., ZHANG, W., & KONE, B. C. (2002) · Biochemical Journal · doi:10.1042/bj20020588 · Cited by 255
Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.
Shurin, G. V., Shurin, M. R., Быковская, С. Н., Shogan, J., Lotze, M. T., & Barksdale, E. M. (2001) · PubMed · Cited by 250
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
T Cell-Derived IL-10 Promotes Lung Cancer Growth by Suppressing Both T Cell and APC Function
Sharma, S., Stolina, M., Lin, Y., Gardner, B., Miller, P. W., Kronenberg, M., & Dubinett, S. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5020 · Cited by 250
Shigematsu, H., Reizis, B., Iwasaki, H., Mizuno, S.-I., Hu, D., Traver, D., Leder, P., Sakaguchi, N., & Akashi, K. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.011 · Cited by 249
Role of tumor-associated gangliosides in cancer progression
Birklé, S., Zeng, G., Gao, L., Yu, R. K., & Aubry, J. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00006-3 · Cited by 239
Altered maturation of peripheral blood dendritic cells in patients with breast cancer
Bella, S. D., Gennaro, M., Vaccari, M., Ferraris, C., Nicola, S., Riva, A., Clerici, M., Greco, M., & Villa, M. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601243 · Cited by 238
Young, M. R., Newby, M., & Wepsic, H. T. (1987) · PubMed · Cited by 231
Characterization of a common precursor population for dendritic cells
del Hoyo, G. M., Martín, P., Vargas, H. H., Ruiz, S., Arias, C. F., & Ardavín, C. (2002) · Nature · doi:10.1038/4151043a · Cited by 222
Minimal Recruitment and Activation of Dendritic Cells Within Renal Cell Carcinoma
Troy, A. J., Summers, K. L., Davidson, P. J. T., Atkinson, C. H., & Hart, D. N. J. (1999) · The Journal of Urology · doi:10.1097/00005392-199905000-00138 · Cited by 220
Dendritic Cells in Antitumor Immune Responses
Gabrilovich, D. I., Nadaf, S., Corak, J., Berzofsky, J. A., & Carbone, D. P. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0140 · Cited by 213
Self-citationSeo, N., Hayakawa, S., Takigawa, M., & Tokura, Y. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01279.x · Cited by 206
Berman, R. M., Suzuki, T., Tahara, H., Robbins, P. D., Narula, S. K., & Lotze, M. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.1.231 · Cited by 205
Péguet-Navarro, J., Sportouch, M., Popa, I., Berthier, O., Schmitt, D., & Portoukalian, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3488 · Cited by 203
Buelens, C., Verhasselt, V., De Groote, D., Thielemans, K., Goldman, M., & Willems, F. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270805 · Cited by 198
Quantitative analysis of vascular endothelial growth factor in primary breast cancer
Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., & Tominaga, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960315)77:6<1101::aid-cncr15>3.0.co;2-5 · Cited by 193
Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells
Caux, C., Massacrier, C., Vanbervliet, B., Barthelemy, C., Liu, Y.-J., & Banchereau, J. (1994) · International Immunology · doi:10.1093/intimm/6.8.1177 · Cited by 192
Chaux, P., Favre, N., Martin, M., & Martin, F. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970807)72:4<619::aid-ijc12>3.0.co;2-6 · Cited by 186
IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert, S., Hosoi, J., Grabbe, S., Asahina, A., & Granstein, R. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1280 · Cited by 184
GM-CSF-secreting melanoma vaccines
Dranoff, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206459 · Cited by 166
Yang, A. S., & Lattime, E. C. (2003) · PubMed · Cited by 165
Nestle, F. O., Burg, G., Fäh, J., Wrone-Smith, T., & Nickoloff, B. J. (1997) · Europe PMC (PubMed Central) · Cited by 164
PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCER
Troy, A., DAVIDSON, P., Atkinson, C. H., & Hart, D. N. J. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)63093-3 · Cited by 151
Ishida, T., Oyama, T., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4842 · Cited by 150
Self-citationHuman renal-cell carcinoma tissue contains dendritic cells
Thurnher, M., Radmayr, C., Ramoner, R. E., Ebner, S., Böck, G., Klocker, H., Romani, N., & Bartsch, G. H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960927)68:1<1::aid-ijc1>3.0.co;2-v · Cited by 149
Interleukin‐10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells
Péguet‐Navarro, J., Moulon, C., Caux, C., Dalbiez‐Gauthier, C., Banchereau, J., & Schmitt, D. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240416 · Cited by 144
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
Salvadori, S., Martinelli, G. P., & Zier, K. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2214 · Cited by 144
STAT3 regulates NF-κB recruitment to the IL-12p40 promoter in dendritic cells
Hoentjen, F., Sartor, R. B., Ozaki, M., & Jobin, C. (2004) · Blood · doi:10.1182/blood-2004-04-1309 · Cited by 142
Saito, H., Tsujitani, S., Ikeguchi, M., Maeta, M., & Kaibara, N. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.725 · Cited by 142
Hoffmann, T. K., Müller‐Berghaus, J., Ferris, R. L., Johnson, J. T., Storkus, W. J., & Whiteside, T. L. (2002) · PubMed · Cited by 142
Control of myeloid differentiation and survival by Stats
Smithgall, T. E., Briggs, S. D., Schreiner, S. J., Lerner, E. C., Cheng, H. Y., & Wilson, M. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203477 · Cited by 136
Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Li, Q., Pan, P., Gu, P., Xu, D., & Chen, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1715 · Cited by 135
Fu, Y., Watson, G. A., Jimenez, J. J., Wang, Y., & Lopez, D. M. (1990) · PubMed · Cited by 127
Ohishi, K., Varnum‐Finney, B., Serda, R. E., Anasetti, C., & Bernstein, I. D. (2001) · Blood · doi:10.1182/blood.v98.5.1402 · Cited by 125
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Hayashi, T., Hideshima, T., Akiyama, M., Raje, N. S., Richardson, P. G. G., Chauhan, D., & Anderson, K. C. (2003) · Blood · doi:10.1182/blood-2002-09-2828 · Cited by 123
Takahashi, A., Kono, K., Ichihara, F., Sugai, H., Fujii, H., & Matsumoto, Y. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0466-8 · Cited by 117
Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo
Ohm, J. E., Shurin, M. R., Esche, C., Lotze, M. T., Carbone, D. P., & Gabrilovich, D. I. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3260 · Cited by 110
Self-citationLissoni, P., Malugani, F., Bonfanti, A., Bucovec, R., Secondino, S., Brivio, F., Bravo, A. F., Ferrante, R., Vigoré, L., Rovelli, F., et al. (2001) · PubMed · Cited by 102
The Notch Ligand Jagged-1 Is Able to Induce Maturation of Monocyte-Derived Human Dendritic Cells
Weijzen, S., Velders, M. P., Elmishad, A. G., Bacon, P. E., Panella, J. R., Nickoloff, B. J., Miele, L., & Kast, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4273 · Cited by 96
IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Ménétrier‐Caux, C., Thomachot, M. C., Alberti, L., Montmain, G., & Blay, J. (2001) · PubMed · Cited by 83
Tumor Escape from Immune Response: Mechanisms and Targets of Activity
Gabrilovich, D. I., & Писарев, В. М. (2003) · Current Drug Targets · doi:10.2174/1389450033490849 · Cited by 81
Self-citationNolan, K. F., Strong, V., Soler, D. F., Fairchild, P. J., Cobbold, S. P., Croxton, R. S., Gonzalo, J.-Á., Rubio, A., Wells, M. P., & Waldmann, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2201 · Cited by 73
Tas, M. P. R., Simons, P. J., Balm, F. J. M., & Drexhage, H. A. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01754410 · Cited by 71
Boehmelt, G., Madruga, J., Ddrfler, P., Briegel, K. J., Schwarz, H., Enrietto, P. J., & Zenke, M. (1995) · Cell · doi:10.1016/0092-8674(95)90417-4 · Cited by 61
Young, M. R., Wright, M. A., & Young, M. E. (1991) · Cancer Immunology Immunotherapy · doi:10.1007/bf01756134 · Cited by 57
Duarte, R. F., & Frank, D. A. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290026231 · Cited by 56
Dikov, M. M., Oyama, T., Cheng, P., Takahashi, T., Takahashi, K., Sepetavec, T., Edwards, B., Adachi, Y., Nadaf, S., Daniel, T., et al. (2001) · PubMed · Cited by 54
Self-citationNosaka, T., & Kitamura, T. (2000) · PubMed · Cited by 39
Organization and function of glycosphingolipids in membrane
Hakomori, S. (2005) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.81.189 · Cited by 29
Ciavarra, R. P., Holterman, D. A., Brown, R. R., Mangiotti, P., Yousefieh, N., Wright, G. L., Schellhammer, P. F., Glass, W. F., & Somers, K. D. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200401000-00002 · Cited by 26
Fan, X., Han, B., Dong, Q., Sha, H., Bao, G., & Liao, M. (2003) · PubMed · Cited by 12
Cited by
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Self-citationApproaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3258 · Cited by 2,049
Metadata
- Authors
- Gabrilovich, D.
- Venue
- Nature Reviews Immunology
- Published
- 2004-12-01
- Volume
- 4
- Issue
- 12
- Pages
- 941-952
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2068971398
- Cited by
- 1,024
- References
- 106
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.